Barclays Forecasts Strong Price Appreciation for Avantor (NYSE:AVTR) Stock

Avantor (NYSE:AVTR) had its price target upped by equities researchers at Barclays from $25.00 to $26.00 in a report issued on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Barclays‘s target price would suggest a potential upside of 18.05% from the stock’s current price.

Several other brokerages also recently issued reports on AVTR. Wells Fargo & Company reduced their price objective on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. UBS Group reissued a “neutral” rating and set a $25.00 price target (down previously from $29.00) on shares of Avantor in a research note on Friday, January 17th. Raymond James lowered their price objective on Avantor from $29.00 to $26.00 and set an “outperform” rating for the company in a research report on Tuesday, January 21st. Finally, Robert W. Baird dropped their price target on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research report on Monday, October 28th. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $27.46.

Avantor Trading Up 0.7 %

Avantor stock opened at $22.03 on Monday. The stock has a market cap of $14.99 billion, a PE ratio of 47.88, a P/E/G ratio of 3.97 and a beta of 1.28. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84. The stock has a 50-day moving average price of $21.71 and a 200 day moving average price of $23.47. Avantor has a 52 week low of $19.59 and a 52 week high of $28.00.

Institutional Trading of Avantor

Hedge funds have recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB increased its position in shares of Avantor by 99.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after acquiring an additional 625 shares during the last quarter. UMB Bank n.a. bought a new position in Avantor during the 3rd quarter valued at $49,000. Nisa Investment Advisors LLC grew its holdings in Avantor by 69.6% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock worth $53,000 after acquiring an additional 835 shares in the last quarter. Global Retirement Partners LLC increased its position in shares of Avantor by 76.7% in the 4th quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock worth $52,000 after purchasing an additional 1,067 shares during the last quarter. Finally, GAMMA Investing LLC raised its stake in shares of Avantor by 89.9% in the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock valued at $70,000 after purchasing an additional 1,285 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.